Billal Tedbirt

16PUBLICATIONS
29CO-AUTHORS
Medical infection agents (incl. prions)Medical mycologyAllergyPharmacogenomicsGene and molecular therapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (16)

|Jun 27, 2026
Comment on 'Incidence and Mortality of Mucous Membrane Pemphigoid in France': reply from authors.

|May 11, 2026
Incidence and Mortality of Mucous Membrane Pemphigoid in France.

|Mar 10, 2026
Prevalence and pathogenicity of anti-SPCA1 and anti-M3AchR autoantibodies in pemphigus.

Billal Tedbirt, Alexandre Lemieux, Maud Maho-Vaillant

|Jan 09, 2026
Persistence of anti-desmoglein 3 antibodies in patients with pemphigus vulgaris in complete remission is associated with restricted isotype diversity and desmoglein 3 ectodomain recognition.

Billal Tedbirt, Sébastien Calbo, Léopoldine Lebourgeois

|Dec 08, 2025
Risk of persistent hypogammaglobulinaemia in children with autoimmune bullous dermatoses treated with rituximab.

S Benkimoun, A Welfringer-Morin, V Barlogis

|Nov 25, 2025
Bullous pemphigoid outcome measurement: a scoping review of outcome heterogeneity and trends in clinical research of treatments.

Marjolein A J Hiel, Billal Tedbirt, Eva W H Korte

Pageof 3

Frequent Collaborators

4 joint publications

Pascal Joly

3 joint publications

Marieke C Bolling

3 joint publications

Eva W H Korte

2 joint publications

Marie-Laure Golinski